STHREE CHEMICALS LLC

Overview

STHREE CHEMICALS LLC is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering CEVIMELINE HYDROCHLORIDE USP; KETOCONAZOLE USP; SODIUM PHENYLBUTYRATE USP; ß-NICOTINAMIDE ADENINE DINUCLEOTIDE; TAFAMIDIS MEGLUMINE.

API / Drug Master Files

STHREE CHEMICALS LLC holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ß-NICOTINAMIDE ADENINE DINUCLEOTIDEActive2024-04-09
• SODIUM PHENYLBUTYRATE USPActive2023-09-29
• CEVIMELINE HYDROCHLORIDE USPActive2023-09-28
• KETOCONAZOLE USPActive2023-07-15
• TAFAMIDIS MEGLUMINEActive2020-08-05

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to STHREE CHEMICALS LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.